Aortic Valve Stenosis - 375 Studies Found
| Active, not recruiting |
: Cerebral Protection in Transcatheter Aortic Valve Replacement : Severe Symptomatic Calcified Native Aortic Valve Stenosis : 2014-08-08 :
|
| Completed |
: Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). : Severe Aortic Stenosis : 2012-04-24 :
|
| Active, not recruiting |
: Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement : Severe Aortic Stenosis : 2012-08-22 : Device: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI) |
| Completed |
: Regression of Myocardial Fibrosis After Aortic Valve Replacement : Aortic Stenosis : 2014-06-24 |
| Completed |
: BIOVALVE - I / II Clincial Investigation :
: 2014-09-23 : Device: BIOVALVE prosthesis Transcatheter Aortic Valve Replacement (TAVR) |
| Completed |
: ACURATE TA™ Valve Implantation: SAVI Registry (Surveillance Plan #2011-02) (TA-SAVI) : Symptomatic Aortic Stenosis : 2014-12-08 : Device: ACURATE TA™ Transapical Aortic Bioprosthesis ACURATE TA™ Transapical Aortic Bioprost |
| Completed |
: Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis :
: Drug: Candesartan |
| Completed |
: The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation : Symptomatic Aortic Stenosis : 2015-08-26 :
|
| Completed |
: Clinical Significance of Collagen Metabolism Changes in Left Cardiac Ventricle : Aortic Stenosis : 2008-06-05 |
| Completed |
: PERIGON Japan Trial : Aortic Stenosis : 2015-12-15 : Device: 17mm MDT-2215 aortic valve bioprosthesis |